B7-H7 / HHLA2 Recombinant Protein
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


B7-H7 / HHLA2 Recombinant Protein
Background:
B7-H7 (HHLA2) is a newly identified B7 family member that regulates human T-cell functions. B7-H7 was previously known as human endogenous retrovirus-H long terminal repeat associating 2 (HHLA2) with unidentified function. Recently, B7-H7 has been identified as a specific ligand for human CD28H. The B7-H7-CD28H pathway strongly promoted CD4+ T-cell proliferation and cytokine production via an AKT-dependent signaling cascade in the presence of TCR signaling, suggesting B7-H7 comprises a new co-stimulatory pathway. The first IgV domain of B7-H7, which presumably binds to a putative receptor, shows the highest homology to other B7 family members.NCBI Gene ID:
11148Swiss Prot:
Q9UM44Accession Number:
NP_009003.1Tag:
Fc TagType:
Recombinant ProteinsSource:
HEK293 cellsField of Research:
ImmunologyPurity:
>90% as determined by reduced SDS-PAGE.Buffer:
Tris with Glycine, Arginine and NaCl, pH7.5Shipping Conditions:
Room TempStorage Conditions:
Lyophilized Protein should be stored at -20˚ C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚ C or -70˚ C. Avoid repeated freeze-thaw cycles.Calculated Molecular Weight:
63.4 kDaApplications Notes:
This protein carries a human IgG1 Fc tag at the C-terminus. The protein has a calculated MW of 63.4 kDa. The protein migrates as 80-100 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.NCBI Official Name:
HERV-H LTR-associating 2NCBI Organism:
Homo sapiensBackground Reference 01:
Ni L., et al., 2017, Mol. Cancer. Ther. 16:1203-1211.Background Reference 02:
Jung K., et al., 2013, Immune. Netw. 13:184-193.Background Reference 03:
Janakiram M., et al., 2015, Clin. Cancer. Res. 21:2359-2366.Other Product Names:
B7-H7, HHLA2, B7 Homolog 7Tested Applications:
ELISA, WBSpecies:
HumanPhysical Properties:
LyophilizedCAS Number:
9000-83-3
